Document is current
Any future updates will be listed below
-
Authors
Khan, Faisal
Seaman, Joseph
Hunter, Tina D.
Ribeiro, Diogo
Laxmanan, Balaji
Kalsekar, Iftekhar
Cumbo-Nacheli, Gustavo
-
Funding
Funding for this research was provided by:
Johnson & Johnson
- License Information
-
More Information
Article History
Received: 20 October 2022
Accepted: 30 April 2023
First Online: 9 May 2023
Declarations
:
: The protocol was approved, and a waiver of informed consent was granted by the WCG Institutional Review Board (20212331), for two of the three investigators. The study was determined to be exempt from review and a waiver of informed consent was granted by Spectrum Health Institutional Review Board (2021–051) for the third investigator.
: Not applicable.
: Iftekhar Kalsekar and Balaji Laxmanan are employees of and own stock in Johnson & Johnson, the study sponsor. Tina D. Hunter and Diogo Ribeiro are employees of CTI Clinical Trial & Consulting, which is a consultant to Johnson & Johnson, the study sponsor. Faisal A. Khan is a paid consultant for Auris / Johnson & Johnson and Pulmonx. Joseph Seaman is a paid consultant for Auris / Johnson & Johnson. Gustavo Cumbo-Nacheli is a paid consultant for Auris / Johnson & Johnson and is the Vice President of the Society for Advanced Bronchoscopy.
